Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C71 - Atypical Parkinsonism

Monday 04/04/22
01:00 PM - 03:00 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Irene Litvan, MD, FAAN
Movement Disorders
Participants should become familiar with the features to suspect the diagnosis of atypical Parkinsonian disorders; the features and clinical diagnostic criteria of the primary tauopathies progressive supranuclear palsy and corticobasal degeneration; and the features and clinical diagnostic to diagnose multiple system atrophy and its differentiation with dementia with Lewy Bodies and Parkinson disease.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
12:30 PM - 01:00 PM PDT Speaker walk in slides
Irene Litvan, MD, FAAN
01:00 PM - 01:45 PM PDT Speaker What is New in the Primary Tauopathies PSP and CBD?
Irene Litvan, MD, FAAN
01:45 PM - 02:00 PM PDT Q&A Questions and Answers
Irene Litvan, MD, FAAN
02:00 PM - 02:45 PM PDT Speaker What is New in the Atypical Synucleonopathies: MSA and DLB?
Horacio C. Kaufmann, MD, FAAN, Patricio Millar Vernetti, MD
02:30 PM - 03:00 PM PDT Discussion Discussion and Closing Remarks
Irene Litvan, MD, FAAN, Horacio C. Kaufmann, MD, FAAN, Patricio Millar Vernetti, MD
02:45 PM - 03:00 PM PDT Q&A Question and Answers
Horacio C. Kaufmann, MD, FAAN, Patricio Millar Vernetti, MD
Faculty Disclosures
Horacio C. Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Irene Litvan, MD, FAAN Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Patricio Millar Vernetti, MD The institution of Dr. Millar Vernetti has received research support from NIH. The institution of Dr. Millar Vernetti has received research support from Theravance. Dr. Millar Vernetti has received personal compensation in the range of $500-$4,999 for serving as a Speaker with WPC.